Treatment of prostate cancer – Endocrine therapies - specialist management - historical notes

Date Note
27/02/2025 Addition of Relugolix (SMC2678), ERFC Feb 25.
06/02/2025 Updated prescribing information gonadorelin analogues, ERWG Jan 2025
16/11/2023 Revised simplified formulary recommendations, ERWG May 23.